Independent and combined effect of bilirubin and smoking on the progression of chronic kidney disease

16Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Objective: Whether serum bilirubin and cigarette smoking affect the risk of renal function decline remains inconclusive. We aimed to test the independent and combined effects of bilirubin and cigarette smoking on the progression of chronic kidney disease (CKD) in hypertensive adults. Methods: The study population consisted of 12,633 patients in the renal sub-study of the China Stroke Primary Prevention Trial. The primary outcome was progression of CKD, defined as a decrease in estimated glomerular filtration rate (eGFR) of ≥30% and to a level of <60 mL/min/1.73 m2 if baseline eGFR was ≥60 mL/min/1.73 m2, or a decrease in eGFR of ≥50% if baseline eGFR was <60 mL/min/1.73 m2, or end-stage renal disease. The secondary outcomes included 1) rapid decline in renal function and 2) annual rate of eGFR decline. Results: The median follow-up duration was 4.4 years. Cigarette smoking had no significant effect on the progression of CKD (odds ratio [OR]: 1.11, 95% confidence interval [95% CI]: 0.78–1.57). However, a significantly lower risk of the primary event (OR: 0.72, 95% CI: 0.55– 0.95) was found in participants in tertile 3 compared to those in tertiles 1–2 for total bilirubin (TBiL) levels. More importantly, there was an interaction between TBiL and smoking status on the primary outcome (P for interaction =0.013). Among ever smokers, TBiL levels had no significant effect on the primary outcome. However, among never smokers, higher TBiL levels were significantly associated with a lower risk of the primary outcome (tertile 3 vs 1–2; OR: 0.53, 95% CI: 0.36–0.78). Similar trends were observed for direct bilirubin and secondary outcomes. Conclusion: Among hypertensive patients, bilirubin was inversely associated with the progression of CKD in never smokers, but not in ever smokers.

References Powered by Scopus

The task force for the management ofarterial hypertension of the european society ofhypertension (esh) and of the european society of cardiology (esc)

4356Citations
N/AReaders
Get full text

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

3441Citations
N/AReaders
Get full text

Bilirubin is an antioxidant of possible physiological importance

3123Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Beyond a measure of liver function—bilirubin acts as a potential cardiovascular protector in chronic kidney disease patients

34Citations
N/AReaders
Get full text

The source and pathophysiologic significance of excreted cadmium

26Citations
N/AReaders
Get full text

Baseline serum bilirubin and risk of first stroke in hypertensive patients

12Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Wang, J., Wang, B., Liang, M., Wang, G., Li, J., Zhang, Y., … Qin, X. (2018). Independent and combined effect of bilirubin and smoking on the progression of chronic kidney disease. Clinical Epidemiology, 10, 121–132. https://doi.org/10.2147/CLEP.S150687

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

50%

Professor / Associate Prof. 2

20%

Researcher 2

20%

Lecturer / Post doc 1

10%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

44%

Nursing and Health Professions 3

33%

Materials Science 1

11%

Agricultural and Biological Sciences 1

11%

Save time finding and organizing research with Mendeley

Sign up for free